News
Filter by
Comunicado
VaxThera and Serum Institute of India Announce a Strategic Collaboration to Strengthen Vaccine Development and Health Security in Colombia
VaxThera SAS announced a strategic collaboration with the Serum Institute of India (SII), a company of the Cyrus Poonawalla Group and the world’s largest vaccine manufacturer, to strengthen vaccine manufacturing and health security in Colombia.
More information
Comunicado
VaxThera achieves LEED® Gold certification for its plant, further solidifying its sustainability commitment.
With a design focused on water and energy efficiency, VaxThera has achieved LEED Gold certification, validated by GBCI, an important milestone that underscores its commitment to people’s wellbeing and environmental performance.
More information
Comunicado
The Ministry of Health and Social Protection and the National Institute of Health (INS) sign an agreement with VaxThera to strengthen health sovereignty
The Special Framework Agreement for Scientific and Technological Cooperation signed between the Ministry of Health, the National Institute of Health (INS), and VaxThera represents an innovation model that seeks to combine efforts to strengthen local capacities in terms of health sovereignty.
More information
Comunicado
VaxThera and SURA launch in Colombia the largest program in the region to prevent cancer associated with HPV infection.
In Colombia, cervical cancer is the leading cause of cancer related death among women between the ages of 20 and 35.
More information
Comunicado
The Colombian company VaxThera secures a major patent grant for a locally developed COVID-19 vaccine.
VaxThera received a patent for its COVID-19 vaccine from the United States Patent and Trademark Office (USPTO).
More information
Comunicado
Colombia avanza en la búsqueda de su soberanía sanitaria, gracias a la construcción de la planta de vacunas de VaxThera
Desde VaxThera estamos comprometidos con la soberanía sanitaria de Colombia donde hace más de 20 años no se producen vacunas.
More information
Comunicado
Meet the women who contribute to research and science for the development of Colombian vaccines
El 51% de VaxThera está compuesto por mujeres, ocupando roles directivos, de investigación y desarrollo de biológicos en el país.
More information
Comunicado
VaxThera builds partnerships and infrastructure to export science and technology in vaccines and biologics
VaxThera, la empresa SURA experta en biotecnología inaugura en Medellín su sede para la investigación en vacunas y biológicos.
More information